Ichnos doses first subject in Phase I/II trial of R/R MM treatment
The company plans to enrol nearly 121 subjects across sites in the US and Australia.
Clinical Trials
Latest in
Clinical Trials
CNS activates first European sites for glioblastoma multiforme trial
Overall Survival is the primary endpoint of the trial analysing Berubicin.
FDA places partial hold on Avidity’s Phase I/II myotonic dystrophy trial
All subjects who are currently receiving AOC 1001 or a placebo can continue to take the treatment.
Positive Phase III lecanemab data for contested Alzheimer’s disease target
Eisai and Biogen reported that lecanemab met the primary endpoint as well as all key secondary endpoints of the trial…
ConcertAI and LSU Health New Orleans partner to boost clinical trial diversity
The partnership will analyse the NCORP programme’s impact on the enrolment of minority populations in trials.
BerGenBio randomises first patient in Covid-19 treatment study
A lead candidate of the company, bemcentinib is an oral inhibitor of AXL.
Pulmatrix concludes subject dosing in Phase I acute migraine trial
The company anticipates reporting pharmacokinetic findings from the trial in the fourth quarter of this year.
Acticor Biotech enrols first subject in Phase II/III stroke treatment trial
The trial will assess the safety and efficacy of glenzocimab plus standard of care to treat acute ischemic stroke.